These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2828821)
21. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Greene DA; Lattimer SA Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor. Greene DA; Lattimer SA Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175 [TBL] [Abstract][Full Text] [Related]
23. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux. Matsumoto T; Ono Y; Kurono M; Kuromiya A; Nakamura K; Bril V J Pharmacol Sci; 2009 Feb; 109(2):203-10. PubMed ID: 19212096 [TBL] [Abstract][Full Text] [Related]
24. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition. Greene DA; Mackway AM Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804 [TBL] [Abstract][Full Text] [Related]
25. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. Stribling D; Mirrlees DJ; Harrison HE; Earl DC Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474 [TBL] [Abstract][Full Text] [Related]
26. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats. Kato N; Mizuno K; Matsubara A; Nakano K; Kurono M; Yagihashi S J Diabetes Complications; 1994; 8(1):27-32. PubMed ID: 8167384 [TBL] [Abstract][Full Text] [Related]
27. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. Hotta N; Kakuta H; Fukasawa H; Kimura M; Koh N; Iida M; Terashima H; Morimura T; Sakamoto N Diabetologia; 1985 Mar; 28(3):176-80. PubMed ID: 3922829 [TBL] [Abstract][Full Text] [Related]
28. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation. Yorek MA; Wiese TJ; Davidson EP; Dunlap JA; Stefani MR; Conner CE; Lattimer SA; Kamijo M; Greene DA; Sima AA Diabetes; 1993 Oct; 42(10):1401-6. PubMed ID: 8397126 [TBL] [Abstract][Full Text] [Related]
29. Prevention of neural myoinositol depletion in diabetic rats by aldose reductase inhibition with tolrestat. Kemper C; Dvornik D Proc Soc Exp Biol Med; 1986 Sep; 182(4):505-10. PubMed ID: 3090558 [TBL] [Abstract][Full Text] [Related]
30. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057 [TBL] [Abstract][Full Text] [Related]
31. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats. Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438 [TBL] [Abstract][Full Text] [Related]
32. Sorbitol, inositol and nerve conduction in diabetes. Gillon KR; Hawthorne JN Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015 [TBL] [Abstract][Full Text] [Related]
33. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats. Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260 [TBL] [Abstract][Full Text] [Related]
34. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Beyer-Mears A; Ku L; Cohen MP Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041 [TBL] [Abstract][Full Text] [Related]
35. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Lowitt S; Malone JI; Salem AF; Korthals J; Benford S Metabolism; 1995 May; 44(5):677-80. PubMed ID: 7752919 [TBL] [Abstract][Full Text] [Related]
36. Increased resistance to hypoxic conduction block in sciatic nerves of diabetic rats: effects of extracellular glucose concentration and of aldose reductase inhibition. Carrington AL; Ettlinger CB; Tomlinson DR J Diabetes Complications; 1994; 8(1):33-9. PubMed ID: 8167385 [TBL] [Abstract][Full Text] [Related]
37. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy. Mizuno K; Kato N; Makino M; Suzuki T; Shindo M J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874 [TBL] [Abstract][Full Text] [Related]
38. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes. Price DE; Airey CM; Alani SM; Wales JK Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261 [TBL] [Abstract][Full Text] [Related]
39. Improvement of nerve conduction velocity in mutant diabetic mice by aldose reductase inhibitor without affecting nerve myo-inositol content. Miwa I; Kanbara M; Okuda J Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1581-2. PubMed ID: 2505939 [TBL] [Abstract][Full Text] [Related]
40. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Carrington AL; Ettlinger CB; Calcutt NA; Tomlinson DR Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]